文献速递肝肾功能剂量调整特殊人群用药治疗药物监测与药物基因组学

儿童急性淋巴细胞白血病大剂量甲氨蝶呤毒性新型与重复验证的临床和遗传风险因素

Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
PubMed 文献 · Pharmacotherapy · 2023-02-27

本研究为单中心回顾性队列研究,纳入接受4000-5000 mg/m2甲氨蝶呤的儿童急性淋巴细胞白血病患者,通过49个单核苷酸多态性(SNP)的胚系基因分型及贝叶斯层次有序回归模型,识别与肌酐升高和甲氨蝶呤清除延迟相关的临床和遗传因素。西班牙裔、极端BMI及美洲原住民遗传 ancestry 与肌酐升高风险增加相关,而rs2838958/SLC19A1和rs7317112/ABCC4次要等位基因与清除延迟风险增加相关。

要点

  • 西班牙裔、BMI<3%或85%-95%、美洲原住民遗传 ancestry 与肌酐升高风险增加相关。
  • rs2838958/SLC19A1和rs7317112/ABCC4次要等位基因与甲氨蝶呤清除延迟风险增加相关。
  • 这些预测因素可能助力个体化甲氨蝶呤毒性风险评估。

核心结论

  • 西班牙裔、BMI<3%、BMI 85%-95%及美洲原住民遗传 ancestry 与肌酐升高风险增加相关。
  • rs2838958/SLC19A1和rs7317112/ABCC4次要等位基因与甲氨蝶呤清除延迟风险增加相关。
  • 这些预测因素可能实现更精准的个体化毒性风险预测。

研究设计与样本

  • 单中心回顾性队列研究,纳入接受4000-5000 mg/m2甲氨蝶呤的儿童急性淋巴细胞白血病患者。
  • 对49个文献报道与甲氨蝶呤处置相关的单核苷酸多态性(SNP)进行胚系基因分型以确定遗传 ancestry 和等位基因状态。
  • 采用贝叶斯层次有序回归模型分析肌酐升高和甲氨蝶呤清除延迟。

主要发现

  • 西班牙裔、BMI<3%、BMI 85%-95%和美洲原住民遗传 ancestry 与肌酐升高风险增加相关。
  • 年龄较大、黑人种族和使用强化监测方案与肌酐升高风险降低相关。
  • 年龄较大、B-ALL(对比T-ALL)以及rs2838958/SLC19A1和rs7317112/ABCC4次要等位基因与清除延迟风险增加相关。
  • 黑人种族、甲氨蝶呤剂量减少和rs2306283/SLCO1B1次要等位基因与清除延迟风险降低相关。

临床怎么用

  • 可依据西班牙裔、极端BMI、美洲原住民遗传 ancestry 等临床和遗传因素识别肌酐升高高风险患儿。
  • 可依据年龄较大、B-ALL及rs2838958/SLC19A1、rs7317112/ABCC4次要等位基因识别清除延迟高风险患儿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Methotrexate (MTX) is a key component of treatment for high-risk pediatric acute lymphoblastic leukemia (ALL) but may cause acute kidney injury and prolonged hospitalization due to delayed clearance. The purpose of this study is to identify clinical and genetic factors that may predict which children are at risk for creatinine increase and prolonged MTX clearance. DESIGN: We conducted a single-center, retrospective cohort study of pediatric patients with ALL who received 4000-5000 mg/m2 of MTX. Measurements We performed germline genotyping to determine genetic ancestry and allele status for 49 single nucleotide polymorphisms (SNPs) identified from the literature as related to MTX disposition. Bayesian hierarchical ordinal regression models for creatinine increase and for prolonged MTX clearance were developed. MAIN RESULTS: Hispanic ethnicity, body mass index (BMI) < 3%, BMI between 85%-95%, and Native American genetic ancestry were found to be associated with an increased risk for creatinine elevation. Older age, Black race, and use of the intensive monitoring protocol were associated with a decreased risk for creatinine elevation. Older age, B- compared to T-ALL, and the minor alleles of rs2838958/SLC19A1 and rs7317112/ABCC4 were associated with an increased risk for delayed clearance. Black race, MTX dose reduction, and the minor allele of rs2306283/SLCO1B1 were found to be associated with a decreased risk for delayed clearance. CONCLUSIONS: These predictors of MTX toxicities may allow for more precise individualized toxicity risk prediction.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Zobeck M, Bernhardt MB, Kamdar KY, et al. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy. 2023. PMID: 36764694. doi:10.1002/phar.2779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。